Oral (per os) administration of this PC promoted the restoration of the anorexic effect of the MC4R agonist, melanotan II (MTII), in mice harboring the obesity-causing mutant form R165W-hMC4R but not in the loxP-flanked transcriptional blocking (loxTB) MC4R-null mice. Here, MC4R is linked to obesity disorder.